Methylthiouracil
- Level
- Commodity
- Parent
- 51181600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51181617This classification denotes an antithyroid agent with the molecular formula C5H6N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QW24888U5F, chemically known as 2,3-dihydro-6-methyl-2-thioxo-4(1h)-pyrimidinone but generally known as methylthiouracil, which bears US NIH Compound Identifier 667493. European Medicines Agency schedules Methylthiouracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08878MIG. The term METHYLTHIOURACIL is an International Non-Proprietary Name. World Health Organization schedules methylthiouracil in its Anatomical Therapeutic Chemical (ATC) Classification. METHYLTHIOURACIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methylthiouracil under HS 29335995 and SITC 51576. As of Q4 2014, METHYLTHIOURACIL remains the US FDA Preferred Term for this commodity. Methylthiouracil bears US NLM identifiers UMLS ID C0025830 and NCI Concept Code C81590. SMILES: S=C1[NH]C(CC(=O)[NH]1)C.
Same parent
Under 51181600 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.